Annals of the American Thoracic Society
Overview
The Annals of the American Thoracic Society is a renowned peer-reviewed journal that focuses on respiratory and critical care medicine. It publishes high-quality research articles, reviews, and clinical studies related to lung diseases, sleep disorders, and critical care management. The journal serves as a valuable resource for healthcare professionals, researchers, and academicians in the field of pulmonary medicine.
Details
Details
Abbr.
Ann Am Thorac Soc
Start
2013
End
Continuing
Frequency
Twelve issues a year, 2015-
p-ISSN
2329-6933
e-ISSN
2325-6621
Country
United States
Language
English
Specialty
Pulmonary Medicine
Metrics
Metrics
h-index / Ranks: 1694
138
SJR / Ranks: 1187
2012
CiteScore / Ranks: 1684
9.30
JIF / Ranks: 640
8.3
Recent Articles
1.
Lichtblau M, Schwarz E, Ulrich T, Schneider S, Bauer M, Furian M, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40085143
Background: Patients with pulmonary vascular disease (PVD) often reveal nocturnal hypoxemia and sleep apnea. We investigated whether exposure to high altitude worsens those conditions. Methods: In a randomized-controlled crossover trial,...
2.
Anton A, Melzer A, Wendt C, Kunisaki K, Dudley R, Baldomero A
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40085063
No abstract available.
3.
Palakshappa J, Rischall M, Strahley A, Cecil A, Prekker M, Driver B, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40085059
Rationale: Conducting pragmatic comparative effectiveness trials in critically ill populations poses distinct challenges. Knowledge gaps exist in how to best conduct pragmatic research while demonstrating respect for critically ill patients...
4.
5.
Johannson K, Liu Z, Southern D, Kalluri M, Gershon A, Farrand E, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40068156
Background The epidemiology of adult interstitial lung disease (ILD) is uncertain, given heterogeneous estimates from prior studies. The objective of this study was to define the incidence, prevalence, and mortality...
6.
Barjaktarevic I, Hixson R, Zhuang Z, Buhr R, Tejwani V, Barr R, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40068143
Background: Reliable data about the natural history of lung function decline in alpha-1 antitrypsin (AAT) deficient Pi*MZ heterozygotes is largely missing. We hypothesized that, in adults with a tobacco smoking...
7.
8.
Rako Z, Cekay M, Yogeswaran A, Yildiz S, Arndt P, Kremer N, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40042816
Rationale: Echocardiographic indicators of pulmonary hypertension have been reported to predict decreased survival in lung cancer. Objective: We tested the hypothesis that this may be associated with impaired right ventricular...
9.
Teijeiro-Paradis R, Munshi L, Ferguson N, Liu K, Fan E
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40042540
Rationale: There is a paucity of evidence around strategies to liberate patients from veno-venous extracorporeal membrane oxygenation (V-V ECMO) for acute respiratory failure. Objectives: The primary aim of this study...
10.
Toporek A, Patel S, Psoter K, Lechtzin N, Riekert K, West N
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40042492
Rationale: Since the approval of elexacaftor/tezacaftor/ivacaftor (ETI), data suggests there have been changes in the management of pulmonary exacerbations (PEx) of Cystic Fibrosis (CF). Objective: Given the subjective nature of...